ADIPOQ and Stroke: A limitation of the secondary analysis might be the limited data on HMW-adiponectin and the lack of data on other adiponectin fractions, which could have resulted in the influence of specific molecular-weight fractions of adiponectin on risk of stroke; this influence remains unclear.